Medtech with an automated skin-prick (SPAT) allergy testing device.
| Date | Round | Amount |
|---|---|---|
| Oct 2023 | Funding round Belgian medtech Hippo Dx raised EUR4.4M, with LRM and Allerfund Ventures, to scale its automated allergy testing device internationally. | $4.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.